ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Syngene International will add a 4,600 m2 facility in Bangalore, India, to an R&D center dedicated to Bristol Myers Squibb. The pharmaceutical services firm will also add 200 researchers—a 40% increase—to its staff as part of an extension of its contract with the US drugmaker through 2030. Syngene has worked with BMS since 1998 and established the dedicated research facility in 2009. The center is the largest BMS R&D site run by a partner, Syngene says.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X